PLT Health Solutions, Inc. announced that Grow in Health S.L., a Spanish nutraceutical company focused on pharmaceutical-style formulations for performance and healthy aging, has launched a new joint...

ZEISS Medical Technology announced that Mexico's Comisión Federal para la Protección contra Riesgos Sanitários (COFEPRIS) approved the ARTEVO® 850 ophthalmic microscope from ZEISS and the MICOR® 700 from...

Bimini Health Tech, a global leader in medical technologies for women's health, announced the achievement of EU Medical Device Regulation (MDR) certification for the company. The achievement marks a...

Boots has launched a new pilot Bone Density Scan Service utilizing Bindex ultrasound technology. With the Bindex device, osteoporosis risk can be detected in a quick assessment available at selected...

Owlet, Inc. the pioneer of smart infant monitoring, announced the launch of Dream Sight and Dream Duo 3 across Australia and New Zealand. The expansion builds on the Company’s 2025 Dream Sock launch...

SQ Innovation announced topline results from the SUBCUT HF II trial of its product Lasix® ONYU, a novel subcutaneous formulation of furosemide for people with heart failure-associated...

For millions of parents, every snack, restaurant meal or birthday party comes with the same worry: Can my child eat this.

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, announced it has submitted a De Novo request to the U.S. Food and Drug Administration seeking...

Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, announced that the U.S. Food and Drug...

DEXA body composition testing has quietly become one of the most consequential health decisions consumers make — informing GLP-1 treatment, sarcopenia screening, and long-term longevity planning....

Modular Devices has been awarded a national group purchasing agreement for Mobile and Modular Pharmacy Cleanrooms with Premier, Inc. Effective March 1, 2026, the new agreement allows Premier...

A new study led by scientists at Northwell Health’s Feinstein Institutes for Medical Research has revealed that defects in different ribosomal proteins lead to a rare blood disorder called...